WallStreetZenWallStreetZen

AnalystsBrendan Smith
Brendan Smith's Stock Forecasts

Sectors:
Healthcare
Industries:
Biotechnology
Analyst Ranking
Bottom 27%
#3363 out of 4572 analysts
Average Return
-19.65%
Win Rate
50%1 out of 2
Risk vs Reward
Poor
Good

Brendan Smith's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Halozyme Therapeutics IncHALO
+0.03%$39.81$39.82
2024-02-28 -
2024-05-02
Buy

Brendan Smith Analyst Color

Get additional color on Brendan Smith's coverage of popular stocks

Brendan Smith's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Halozyme Therapeutics IncHALO
1Buy$54.00+35.61%Initiates Coverage On
2 months ago
Denali Therapeutics IncDNLI
1BuyN/AN/AInitiates Coverage On
a year ago
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.